Harvard Bioscience HBIO
NASDAQ HBIO
$8.17 -0.17 (-2.04%)
As of: Oct 21, 2026 · 10:56 AM EDT

Harvard Bioscience (HBIO) Cash from Restructuring (2010 - 2016)

Updated

Analysis

Harvard Bioscience (HBIO) Cash from Restructuring (2010 - 2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 257.76 Bn 236.79 Bn 4.88 Bn
2 Abbott Laboratories 171.54 Bn 141.97 Bn 7.27 Bn
3 Danaher 162.87 Bn 146.68 Bn 3.61 Bn
4 Intuitive Surgical 151.38 Bn 130.80 Bn 1.96 Bn
5 Medtronic 119.65 Bn 84.91 Bn 6.34 Bn
6 Stryker 113.70 Bn 99.82 Bn 4.50 Bn
7 Boston Scientific 65.12 Bn 59.89 Bn 3.85 Bn
8 Becton Dickinson 53.53 Bn 50.68 Bn 2.32 Bn
9 Edwards Lifesciences 50.78 Bn 34.78 Bn 1.35 Bn
10 Harvard Bioscience 36.98 Mn 7.95 Mn 12.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2016 -27,000.00
Dec 31, 2015 -6,000.00
Sep 30, 2015 -15,000.00
Jun 30, 2015 -64,000.00
Sep 30, 2014 -2,000.00
Jun 30, 2014 -16,000.00
Mar 31, 2014 -102,000.00
Dec 31, 2013 -97,000.00
Sep 30, 2013 95,000.00
Jun 30, 2013 -23,000.00
Mar 31, 2013 -21,000.00
Dec 31, 2011 -70,000.00
Sep 30, 2011 308,000.00
Jun 30, 2011 -28,000.00
Dec 31, 2010 79,000.00
API Access

Harvard Bioscience Cash from Restructuring API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-restructuring&ticker=HBIO&period=max&api_key=YOUR_API_KEY